View in EDS HTML Full Text PDF Full Text

Live two‐way video versus face‐to‐face treatment for depression, anxiety, and obsessive‐compulsive disorder: A 24‐week randomized controlled trial.

Saved in:
Bibliographic Details
Title: Live two‐way video versus face‐to‐face treatment for depression, anxiety, and obsessive‐compulsive disorder: A 24‐week randomized controlled trial.
Authors: Kishimoto, Taishiro (AUTHOR), Kinoshita, Shotaro (AUTHOR), Kitazawa, Momoko (AUTHOR), Hishimoto, Akitoyo (AUTHOR), Asami, Takeshi (AUTHOR), Suda, Akira (AUTHOR), Bun, Shogyoku (AUTHOR), Kikuchi, Toshiaki (AUTHOR), Sado, Mitsuhiro (AUTHOR), Takamiya, Akihiro (AUTHOR), Mimura, Masaru (AUTHOR), Sato, Yasunori (AUTHOR), Takemura, Ryo (AUTHOR), Nagashima, Kengo (AUTHOR), Nakamae, Takashi (AUTHOR), Abe, Yoshinari (AUTHOR), Kanazawa, Tetsufumi (AUTHOR), Kawabata, Yasuo (AUTHOR), Tomita, Hiroaki (AUTHOR), Abe, Koichi (AUTHOR)
Source: Psychiatry & Clinical Neurosciences. Apr2024, Vol. 78 Issue 4, p220-228. 9p.
Subjects: Obsessive-compulsive disorder, Anxiety disorders, Randomized controlled trials, Treatment effectiveness, Mental health surveys, Psychiatric treatment
Abstract: Aim: Live two‐way video, easily accessible from home via smartphones and other devices, is becoming a new way of providing psychiatric treatment. However, lack of evidence for real‐world clinical setting effectiveness hampers its approval by medical insurance in some countries. Here, we conducted the first large‐scale pragmatic, randomized controlled trial to determine the effectiveness of long‐term treatment for multiple psychiatric disorders via two‐way video using smartphones and other devices, which are currently the primary means of telecommunication. Methods: This randomized controlled trial compared two‐way video versus face‐to‐face treatment for depressive disorder, anxiety disorder, and obsessive‐compulsive disorder in the subacute/maintenance phase during a 24‐week period. Adult patients with the above‐mentioned disorders were allocated to either a two‐way video group (≥50% video sessions) or a face‐to‐face group (100% in‐person sessions) and received standard treatment covered by public medical insurance. The primary outcome was the 36‐Item Short‐Form Health Survey Mental Component Summary (SF‐36 MCS) score. Secondary outcomes included all‐cause discontinuation, working alliance, adverse events, and the severity rating scales for each disorder. Results: A total of 199 patients participated in this study. After 24 weeks of treatment, two‐way video treatment was found to be noninferior to face‐to‐face treatment regarding SF‐36 MCS score (48.50 vs 46.68, respectively; p < 0.001). There were no significant differences between the groups regarding most secondary end points, including all‐cause discontinuation, treatment efficacy, and satisfaction. Conclusion: Two‐way video treatment using smartphones and other devices, was noninferior to face‐to‐face treatment in real‐world clinical settings. Modern telemedicine, easily accessible from home, can be used as a form of health care. [ABSTRACT FROM AUTHOR]
Copyright of Psychiatry & Clinical Neurosciences is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 176497092
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Live two‐way video versus face‐to‐face treatment for depression, anxiety, and obsessive‐compulsive disorder: A 24‐week randomized controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kishimoto%2C+Taishiro%22&quot;&gt;Kishimoto, Taishiro&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kinoshita%2C+Shotaro%22&quot;&gt;Kinoshita, Shotaro&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kitazawa%2C+Momoko%22&quot;&gt;Kitazawa, Momoko&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hishimoto%2C+Akitoyo%22&quot;&gt;Hishimoto, Akitoyo&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Asami%2C+Takeshi%22&quot;&gt;Asami, Takeshi&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Suda%2C+Akira%22&quot;&gt;Suda, Akira&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bun%2C+Shogyoku%22&quot;&gt;Bun, Shogyoku&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kikuchi%2C+Toshiaki%22&quot;&gt;Kikuchi, Toshiaki&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sado%2C+Mitsuhiro%22&quot;&gt;Sado, Mitsuhiro&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Takamiya%2C+Akihiro%22&quot;&gt;Takamiya, Akihiro&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mimura%2C+Masaru%22&quot;&gt;Mimura, Masaru&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sato%2C+Yasunori%22&quot;&gt;Sato, Yasunori&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Takemura%2C+Ryo%22&quot;&gt;Takemura, Ryo&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Nagashima%2C+Kengo%22&quot;&gt;Nagashima, Kengo&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Nakamae%2C+Takashi%22&quot;&gt;Nakamae, Takashi&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Abe%2C+Yoshinari%22&quot;&gt;Abe, Yoshinari&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kanazawa%2C+Tetsufumi%22&quot;&gt;Kanazawa, Tetsufumi&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kawabata%2C+Yasuo%22&quot;&gt;Kawabata, Yasuo&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Tomita%2C+Hiroaki%22&quot;&gt;Tomita, Hiroaki&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Abe%2C+Koichi%22&quot;&gt;Abe, Koichi&lt;/searchLink&gt; (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Psychiatry+%26+Clinical+Neurosciences%22&quot;&gt;Psychiatry &amp; Clinical Neurosciences&lt;/searchLink&gt;. Apr2024, Vol. 78 Issue 4, p220-228. 9p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Obsessive-compulsive+disorder%22&quot;&gt;Obsessive-compulsive disorder&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Anxiety+disorders%22&quot;&gt;Anxiety disorders&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Randomized+controlled+trials%22&quot;&gt;Randomized controlled trials&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Treatment+effectiveness%22&quot;&gt;Treatment effectiveness&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Mental+health+surveys%22&quot;&gt;Mental health surveys&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Psychiatric+treatment%22&quot;&gt;Psychiatric treatment&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Aim: Live two‐way video, easily accessible from home via smartphones and other devices, is becoming a new way of providing psychiatric treatment. However, lack of evidence for real‐world clinical setting effectiveness hampers its approval by medical insurance in some countries. Here, we conducted the first large‐scale pragmatic, randomized controlled trial to determine the effectiveness of long‐term treatment for multiple psychiatric disorders via two‐way video using smartphones and other devices, which are currently the primary means of telecommunication. Methods: This randomized controlled trial compared two‐way video versus face‐to‐face treatment for depressive disorder, anxiety disorder, and obsessive‐compulsive disorder in the subacute/maintenance phase during a 24‐week period. Adult patients with the above‐mentioned disorders were allocated to either a two‐way video group (≥50% video sessions) or a face‐to‐face group (100% in‐person sessions) and received standard treatment covered by public medical insurance. The primary outcome was the 36‐Item Short‐Form Health Survey Mental Component Summary (SF‐36 MCS) score. Secondary outcomes included all‐cause discontinuation, working alliance, adverse events, and the severity rating scales for each disorder. Results: A total of 199 patients participated in this study. After 24 weeks of treatment, two‐way video treatment was found to be noninferior to face‐to‐face treatment regarding SF‐36 MCS score (48.50 vs 46.68, respectively; p &lt; 0.001). There were no significant differences between the groups regarding most secondary end points, including all‐cause discontinuation, treatment efficacy, and satisfaction. Conclusion: Two‐way video treatment using smartphones and other devices, was noninferior to face‐to‐face treatment in real‐world clinical settings. Modern telemedicine, easily accessible from home, can be used as a form of health care. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Psychiatry &amp; Clinical Neurosciences is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=176497092
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/pcn.13618
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 220
    Subjects:
      – SubjectFull: Obsessive-compulsive disorder
        Type: general
      – SubjectFull: Anxiety disorders
        Type: general
      – SubjectFull: Randomized controlled trials
        Type: general
      – SubjectFull: Treatment effectiveness
        Type: general
      – SubjectFull: Mental health surveys
        Type: general
      – SubjectFull: Psychiatric treatment
        Type: general
    Titles:
      – TitleFull: Live two‐way video versus face‐to‐face treatment for depression, anxiety, and obsessive‐compulsive disorder: A 24‐week randomized controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kishimoto, Taishiro
      – PersonEntity:
          Name:
            NameFull: Kinoshita, Shotaro
      – PersonEntity:
          Name:
            NameFull: Kitazawa, Momoko
      – PersonEntity:
          Name:
            NameFull: Hishimoto, Akitoyo
      – PersonEntity:
          Name:
            NameFull: Asami, Takeshi
      – PersonEntity:
          Name:
            NameFull: Suda, Akira
      – PersonEntity:
          Name:
            NameFull: Bun, Shogyoku
      – PersonEntity:
          Name:
            NameFull: Kikuchi, Toshiaki
      – PersonEntity:
          Name:
            NameFull: Sado, Mitsuhiro
      – PersonEntity:
          Name:
            NameFull: Takamiya, Akihiro
      – PersonEntity:
          Name:
            NameFull: Mimura, Masaru
      – PersonEntity:
          Name:
            NameFull: Sato, Yasunori
      – PersonEntity:
          Name:
            NameFull: Takemura, Ryo
      – PersonEntity:
          Name:
            NameFull: Nagashima, Kengo
      – PersonEntity:
          Name:
            NameFull: Nakamae, Takashi
      – PersonEntity:
          Name:
            NameFull: Abe, Yoshinari
      – PersonEntity:
          Name:
            NameFull: Kanazawa, Tetsufumi
      – PersonEntity:
          Name:
            NameFull: Kawabata, Yasuo
      – PersonEntity:
          Name:
            NameFull: Tomita, Hiroaki
      – PersonEntity:
          Name:
            NameFull: Abe, Koichi
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 13231316
          Numbering:
            – Type: volume
              Value: 78
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Psychiatry & Clinical Neurosciences
              Type: main
ResultId 1